{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:50:10Z","timestamp":1784191810471,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.cyto.2021.155619","type":"journal-article","created":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T16:47:44Z","timestamp":1623602864000},"page":"155619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Cytokine and chemokine profiles in episodes of persistent high-risk febrile neutropenia in children with cancer"],"prefix":"10.1016","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0400-1479","authenticated-orcid":false,"given":"Lorena I.","family":"Tapia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Olivares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3565-5467","authenticated-orcid":false,"given":"Juan P.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"De la Maza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Contardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Tordecilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Varas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Zubieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Venegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximena","family":"Claverie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2985-614X","authenticated-orcid":false,"given":"Milena","family":"Villarroel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda E.","family":"Santolaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2021.155619_b0005","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.hoc.2017.08.004","article-title":"Neutropenic fever","volume":"31","author":"White","year":"2017","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.cyto.2021.155619_b0010","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/INF.0b013e318124aa44","article-title":"Admission clinical and laboratory factors associated with death in children with cancer during a febrile neutropenic episode","volume":"26","author":"Santolaya","year":"2007","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.cyto.2021.155619_b0015","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1200\/JCO.2016.71.7017","article-title":"Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update","volume":"35","author":"Lehrnbecher","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cyto.2021.155619_b0020","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1086\/342064","article-title":"Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia","volume":"35","author":"Santolaya","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cyto.2021.155619_b0025","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/01.inf.0000436128.49972.16","article-title":"Prospective validation of a risk prediction model for severe sepsis in children with cancer and high-risk febrile neutropenia","volume":"32","author":"Santolaya","year":"2013","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.cyto.2021.155619_b0030","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/INF.0b013e31822a37d7","article-title":"Diagnosis of bacteremia in febrile neutropenic episodes in children with cancer: microbiologic and molecular approach","volume":"30","author":"Santolaya","year":"2011","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.cyto.2021.155619_b0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/MOP.0000000000000708","article-title":"Treatment of fever in neutropenia in pediatric oncology patients","volume":"31","author":"Lehrnbecher","year":"2019","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.cyto.2021.155619_b0040","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/INF.0b013e3181e7db7f","article-title":"Risk factors associated with invasive fungal disease in children with cancer and febrile neutropenia: a prospective multicenter evaluation","volume":"29","author":"Villarroel","year":"2010","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.cyto.2021.155619_b0045","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/QCO.0b013e32833ef7d1","article-title":"New molecular and surrogate biomarker-based tests in the diagnosis of bacterial and fungal infection in febrile neutropenic patients","volume":"23","author":"Chen","year":"2010","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.cyto.2021.155619_b0050","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4067\/s0716-10182018000200140","article-title":"Microorganismos aislados de hemocultivos en ni\u00f1os con c\u00e1ncer y neutropenia febril de alto riesgo en cinco hospitales de Santiago, Chile, per\u00edodo 2012\u20132015","volume":"35","author":"Maldonado","year":"2018","journal-title":"Rev Chil Infectol"},{"key":"10.1016\/j.cyto.2021.155619_b0055","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/INF.0b013e3181673c3c","article-title":"Predictors of severe sepsis not clinically apparent during the first twenty-four hours of hospitalization in children with cancer, neutropenia, and fever: a prospective, multicenter trial","volume":"27","author":"Santolaya","year":"2008","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.cyto.2021.155619_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pbc.27887","article-title":"Updated systematic review and meta-analysis of the predictive value of serum biomarkers in the assessment and management of fever during neutropenia in children with cancer","volume":"66","author":"Arif","year":"2019","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.cyto.2021.155619_b0065","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2141.2009.07862.x","article-title":"Immune function in children under chemotherapy for standard risk acute lymphoblastic leukaemia \u2013 a prospective study of 20 paediatric patients","volume":"147","author":"Eyrich","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cyto.2021.155619_b0070","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/joim.12100","article-title":"Decreased functional T lymphocyte-mediated cytokine responses in patients with chemotherapy-induced neutropenia","volume":"274","author":"\u00d6hrmalm","year":"2013","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.cyto.2021.155619_b0075","series-title":"Inmunologia Celular y Molecular","first-page":"243","article-title":"Citoquinas","author":"Abbas","year":"2002"},{"key":"10.1016\/j.cyto.2021.155619_b0080","first-page":"3819","article-title":"Predictive value of procalcitonin and interleukin-6 for bacterial infection in children with cancer and febrile neutropenia","volume":"26","author":"Loeffen","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.cyto.2021.155619_b0085","first-page":"2863","article-title":"Does procalcitonin, C-reactive protein, or interleukin-6 test have a role in the diagnosis of severe infection in patients with febrile neutropenia? A systematic review and meta-analysis","volume":"23","author":"Wu","year":"2015","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.cyto.2021.155619_b0090","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s00277-017-3128-1","article-title":"Diagnostic value of sTREM-1, IL-8, PCT, and CRP in febrile neutropenia after autologous stem cell transplantation","volume":"96","author":"Michel","year":"2017","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.cyto.2021.155619_b0095","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4067\/S0716-10182011000400003","article-title":"Diagn\u00f3stico y tratamiento de la neutropenia febril en ni\u00f1os con c\u00e1ncer Consenso de la Sociedad Latinoamericana de Infectolog\u00eda Pedi\u00e1trica","volume":"28","author":"Paganini","year":"2011","journal-title":"Rev. Chil. Infectol."},{"key":"10.1016\/j.cyto.2021.155619_b0100","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1093\/jac\/dky244","article-title":"Efficacy of pre-emptive versus empirical antifungal therapy in children with cancer and high-risk febrile neutropenia: a randomized clinical trial","volume":"73","author":"Santolaya","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.cyto.2021.155619_b0105","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4103\/0255-0857.115624","article-title":"Interleukin-5, interleukin-6, interleukin-8 and tumour necrosis factor-alpha levels obtained within 24-h of admission do not predict high-risk infection in children with febrile neutropenia","volume":"31","author":"Aggarwal","year":"2013","journal-title":"Indian J. Med. Microbiol."},{"key":"10.1016\/j.cyto.2021.155619_b0110","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3109\/08880018.2015.1057310","article-title":"Adrenomedullin \u2013 a new marker in febrile neutropenia: comparison with CRP and procalcitonin","volume":"32","author":"Demirkaya","year":"2015","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.cyto.2021.155619_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12887-016-0766-8","article-title":"Prospective cohort study of procalcitonin levels in children with cancer presenting with febrile neutropenia","volume":"17","author":"Hemming","year":"2017","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.cyto.2021.155619_b0120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/MPH.0000000000000057","article-title":"Clinical and laboratory parameter dynamics as markers of blood stream infections in pediatric oncology patients with fever and neutropenia","volume":"36","author":"Hazan","year":"2014","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.cyto.2021.155619_b0125","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1182\/blood-2005-01-015081","article-title":"Regulation of systemic and local neutrophil responses by G-CSF during pulmonary Pseudomonas aeruginosa infection","volume":"109","author":"Gregory","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2021.155619_b0130","first-page":"1","article-title":"Broad-spectrum antibiotic or G-CSF as potential countermeasures for impaired control of bacterial infection associated with an SPE Exposure during spaceflight","volume":"10","author":"Li","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2021.155619_b0135","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1371\/journal.pone.0037334","article-title":"Granulocyte colony-stimulating factor protects mice during respiratory virus infections","volume":"7","author":"Hermesh","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2021.155619_b0140","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4049\/jimmunol.1201044","article-title":"IL-6 controls the innate immune response against listeria monocytogenes via classical IL-6 signaling","volume":"190","author":"Hoge","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2021.155619_b0145","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/cmi.2014.80","article-title":"Soluble interleukin-6 receptor is elevated during influenza A virus infection and mediates the IL-6 and IL-32 inflammatory cytokine burst","volume":"12","author":"Wang","year":"2015","journal-title":"Cell. Mol. Immunol."},{"issue":"260\u2013265","key":"10.1016\/j.cyto.2021.155619_b0150","article-title":"Interleukin-6 as a diagnostic marker for infection in critically ill patients: a systematic review and meta-analysis","volume":"37","author":"Iwase","year":"2019","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.cyto.2021.155619_b0155","first-page":"15238","article-title":"Accuracy of serum interleukin (IL)-6 in sepsis diagnosis: a systematic review and meta-analysis","volume":"8","author":"Hou","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.cyto.2021.155619_b0160","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.autrev.2013.09.010","article-title":"Fms-like tyrosine kinase 3 ligand-dependent dendritic cells in autoimmune inflammation","volume":"13","author":"Ramos","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cyto.2021.155619_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-06784-x","article-title":"CXCL10 is produced in hepatitis A virus-infected cells in an IRF3-dependent but IFN-independent manner","volume":"7","author":"Sung","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cyto.2021.155619_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0100978","article-title":"Synergistic up-regulation of CXCL10 by virus and IFN \u03b3 in human airway epithelial cells","volume":"9","author":"Oslund","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2021.155619_b0175","first-page":"121","article-title":"CXCL10\/IP-10 in infectious diseases pathogenesis and potential therapeutic implications","volume":"22","author":"Liu","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cyto.2021.155619_b0180","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jcv.2017.03.003","article-title":"Serum IFN-g-induced protein 10 (IP-10) as a biomarker for severity of acute respiratory infection in healthy adults","volume":"90","author":"Hayney","year":"2017","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.cyto.2021.155619_b0185","doi-asserted-by":"crossref","DOI":"10.1097\/INF.0b013e31825c4b7e","article-title":"Frequency and clinical outcome of respiratory viral infections and mixed viral-bacterial infections in children with cancer, fever and neutropenia","volume":"31","author":"Torres","year":"2012","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.cyto.2021.155619_b0190","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/INF.0000000000001209","article-title":"Respiratory viral infections and coinfections in children with cancer, fever and neutropenia","volume":"35","author":"Torres","year":"2016","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.cyto.2021.155619_b0195","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1469-0691.2011.03490.x","article-title":"Evaluation of Th1\/Th2 cytokines as a rapid diagnostic tool for severe infection in paediatric haematology\/oncology patients by the use of cytometric bead array technology","volume":"17","author":"Tang","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.cyto.2021.155619_b0200","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.cmi.2016.09.013","article-title":"Comparison of the diagnostic power of cytokine patterns and procalcitonin for predicting infection among paediatric haematology\/oncology patients","volume":"22","author":"Xia","year":"2016","journal-title":"Clin. Microbiol. Infect."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621002052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621002052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:07:13Z","timestamp":1760908033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466621002052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":40,"alternative-id":["S1043466621002052"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155619","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokine and chemokine profiles in episodes of persistent high-risk febrile neutropenia in children with cancer","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"155619"}}